Swine Flu News and Research

RSS
Swine Flu or influenza A (H1N1) is a new flu virus of swine origin that first caused illness in Mexico and the United States in March and April, 2009. It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread, mainly through the coughs and sneezes of people who are sick with the virus, but it may also be spread by touching infected objects and then touching your nose or mouth. Novel H1N1 infection has been reported to cause a wide range of flu-like symptoms, including fever, cough, sore throat, body aches, headache, chills and fatigue. In addition, many people also have reported nausea, vomiting and/or diarrhea.
New technology to diagnose influenza quickly

New technology to diagnose influenza quickly

BiondVax: Priming with universal flu vaccine makes conventional bird flu vaccine effective against pandemic strains

BiondVax: Priming with universal flu vaccine makes conventional bird flu vaccine effective against pandemic strains

Best way to protect infants from influenza is to vaccinate rest of the family

Best way to protect infants from influenza is to vaccinate rest of the family

NanoViricides, LRRI sign NDA for IND-enabling efficacy studies on FluCide drug candidates

NanoViricides, LRRI sign NDA for IND-enabling efficacy studies on FluCide drug candidates

H7 influenza may spillover repeatedly into humans, say scientists

H7 influenza may spillover repeatedly into humans, say scientists

NanoViricides submits letter of intent to file Orphan Drug Application with EMA for DengueCide

NanoViricides submits letter of intent to file Orphan Drug Application with EMA for DengueCide

NACC recommendations address established pain therapies and preview potential future advances

NACC recommendations address established pain therapies and preview potential future advances

NanoViricides files Orphan Drug application with FDA for DengueCide

NanoViricides files Orphan Drug application with FDA for DengueCide

Sinovac Beijing receives GMP certificate for its proprietary vaccines

Sinovac Beijing receives GMP certificate for its proprietary vaccines

To avoid difficulties experienced during SARS epidemic, China must remain transparent in H7N9 efforts

To avoid difficulties experienced during SARS epidemic, China must remain transparent in H7N9 efforts

Anti-vaccination messages spread more easily than positive ones on Twitter, researchers find

Anti-vaccination messages spread more easily than positive ones on Twitter, researchers find

BioCryst Pharmaceuticals receives preliminary comment letter from FDA on peramivir

BioCryst Pharmaceuticals receives preliminary comment letter from FDA on peramivir

UCLA researchers predict hotspots for future outbreaks of influenza virus

UCLA researchers predict hotspots for future outbreaks of influenza virus

Influenza drug: an interview with Dr Jenny McKimm-Breschkin, CSIRO

Influenza drug: an interview with Dr Jenny McKimm-Breschkin, CSIRO

Nursing home patients with pneumonia may need viral screening

Nursing home patients with pneumonia may need viral screening

Influenza vaccine linked to narcolepsy in children in England

Influenza vaccine linked to narcolepsy in children in England

NanoViricides retires Series C Convertible Preferred Stock previously purchased by Seaside

NanoViricides retires Series C Convertible Preferred Stock previously purchased by Seaside

New molecular compounds can kill the influenza virus

New molecular compounds can kill the influenza virus

FluGen's REDEE FLU vaccine protects against both H5N1 and H3N2 strains

FluGen's REDEE FLU vaccine protects against both H5N1 and H3N2 strains

1 in 5 people infected with swine flu during first year of epidemic, WHO-led study shows

1 in 5 people infected with swine flu during first year of epidemic, WHO-led study shows